Search Results
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
LANCE Ultra ULight Streptavidin Peptide Substrate, 10nmoles
Streptavidin labeled with ULight™ dye.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Product information
Overview
The versatility of LANCE TR-FRET technology allows the assembly of donor and acceptor dye pairs for use in protein binding and other assays. Choose your preferred donor- and acceptor-labeled reagents to design your own assay. This is assay design at its most flexible; featuring the most common affinity biomolecules and europium chelate-labeling reagents. LANCE toolbox reagents can be used to design a variety of assays, including kinase, protein-protein interaction, protein-nucleic acid interaction, protein-small molecule interaction, epigenetic, receptor-ligand binding, nuclear receptor, receptor dimerization, ubiquitination and other post-translational modifications, protease, and other binding and enzymatic assays.
Specifications
| Antibody Conjugates |
Streptavidin
|
|---|---|
| Application |
Enzymatic
Protein-protein interactions
Protein Analysis & Detection
|
| Automation Compatible |
Yes
|
| Brand |
LANCE Ultra
|
| Detection Method |
Time-Resolved Fluorescence (TRF)
TR-FRET
|
| Experimental Type |
In vitro
|
| Fluorophore |
ULight
|
| Format |
Microplates
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Unit Size |
10 nmol
|
Resources
Here, we demonstrate the utility and benefits of using LANCE Ultra TR-FRET assay technology for identifying and characterizing PD...
SDS, COAs, Manuals and more
Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.
Related products
USD 524.69 - USD 1,595.00
of 3
How can we help you?
We are here to answer your questions.
